Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Myasthenia Gravis × tocilizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myasthenia Gravis 1 Multiple Myeloma 1 Leukemia 1 Infections 1 Graft vs Host Disease 1 Cancer Therapy-related Cardiovascular Toxicity 1 Burkitt Lymphoma 1 Arthritis, Rheumatoid 1

Interventions

Pyridostigmine Bromide 4 Tacrolimus 2 Prednisone 2 Mycophenolic Acid 2 tocilizumab 1 sargramostim 1 Thymectomy 1 Tablets 1 Steroids 1 Sternotomy 1 Rituximab 1 Methylprednisolone 1 Methotrexate 1 Immunosuppressive Agents 1 Immunoglobulins, Intravenous 1 HBM9161 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Exercise 1 Cyclosporine 1 Cyclophosphamide 1 Azathioprine 1 Amifampridine 1 Alkalies 1 Albuterol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05716035 2024-01-22

tMG-E

Tang-Du Hospital

Phase 2/3 Unknown

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡